OCUGEN INC revenue breakdown overview

OCUGEN INC revenue for the last year amounted to 2.72 M EUR, the most of which — 5.47 M EUR — came from its highest performing source at the moment, Novel Gene and Cell Therapies and Vaccines, the year earlier bringing 34.83 k EUR. The greatest contribution to the revenue figure was made by United States — last year it brought OCUGEN INC 5.47 M EUR, and the year before that — 34.83 k EUR.